Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etanercept + Methotrexate vs DMARDs in Early RA
NCT00783536Phase 4Withdrawn
- Sponsor
- Pfizer
- Start
- Nov 2008
- Primary completion
- Jun 2010
- Modality
- Fc-Fusion Proteins
01
Overview
A Phase 4 trial of etanercept in rheumatoid arthritis (RA), sponsored by Pfizer. Planned start Nov 2008; status: withdrawn.
02
Drugs
etanercept
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00783536.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00783536.